Shares of Ion Beam Applications SA (OTCMKTS:IOBCF – Get Free Report) traded down 2% during trading on Wednesday . The stock traded as low as $17.93 and last traded at $17.93. 535 shares were traded during trading, a decline of 35% from the average session volume of 829 shares. The stock had previously closed at $18.30.
Ion Beam Applications Price Performance
The business has a 50 day moving average price of $18.87 and a two-hundred day moving average price of $17.62.
Ion Beam Applications Company Profile
Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.
In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.
Featured Stories
- Five stocks we like better than Ion Beam Applications
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Ion Beam Applications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ion Beam Applications and related companies with MarketBeat.com's FREE daily email newsletter.
